Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,150 public trials 307 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

NCT05929222

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico Sassuolo, Modena (MO), Italy
  • Azienda Ospedaliera Nazionale Ss Antonio E Biagio E C Arrigo, SCDU Ematologia Alessandria, Italy
  • AORN San Giuseppe Moscati Avellino, U.O.C. Ematologia e Trapianto Emopoietico Avellino, Italy
  • Centro Di Riferimento Oncologico Di Aviano, S.O.C. Oncologia Medica e dei Tumori Immunocorrelati Aviano, Italy
View all 49 locations
View Trial Details
Recruiting

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT06624085

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Saddleback Memorial Medical Center Laguna Hills, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • University of California Los Angeles (UCLA) - Cancer Care - Santa Monica Santa Monica, California, United States
View all 18 locations
View Trial Details
Recruiting

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

NCT07509151

Conditions
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Research Site Adelaide, Australia
  • Research Site Fitzroy, Australia
  • Research Site Heidelberg, Australia
  • Research Site Nedlands, Australia
View all 44 locations
View Trial Details
Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610

Conditions
Astrocytoma, Glioblastoma, Glioma, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado, United States
  • Local Institution - 2105 Orlando, Florida, United States
View all 68 locations
View Trial Details
Recruiting

RAT-HEMATO : Return to Work After Malignant Hemopathy

NCT06262789

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Angers University hospital Angers, France
  • Brest University Hospital, Morvan Site Brest, France
  • Caen University hospital Caen, France
  • Rennes University Hospital, Pontchaillou site Rennes, France
View Trial Details
Recruiting

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

NCT07082803

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Stanford Medicine Cancer Center Palo Alto, California, United States
  • The START Center for Cancer Care - Midwest Grand Rapids, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 14 locations
View Trial Details

Related conditions